Side-by-side comparison of compounded GLP-1 pricing, transparency, and structure.
Flat vs tieredReviewed June 1, 2026True monthly costSource-verified
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
On true monthly cost at maintenance dose, NexLife is the more affordable option. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range.
Henry Meds's advertised rate is $179-$269/mo but actual realistic cost is $269+/mo for tirzepatide programs. Henry Meds' own program/legal pricing page lists semaglutide injection at approximately $297/mo. Forbes Health corroborates this rate.
Pricing Comparison: NexLife vs Henry Meds
Plan
Advertised
True monthly
Dose increases?
Shipping
Provider care
NexLife (tirzepatide)
$186/mo
$186/mo at every dose
No
Yes
Yes
Henry Meds (tirzepatide)
$179-$269/mo
$269+/mo for tirzepatide programs
No
Yes
Yes
NexLife (semaglutide)
$145/mo
$145/mo at every dose
No
Yes
Yes
Henry Meds (semaglutide)
$179/mo starter
~$297/mo per Henry's program/legal pricing page
No
Yes
Yes
Pricing reviewed: June 1, 2026. Source: Henry Meds program/legal pricing page, Forbes Health corroboration.
What Henry Meds Does Well
Established telehealth brand. Often offers flat-rate pricing (less dose escalation than dose-tiered competitors).
The Pricing Gap
Higher base monthly rate than several competitors. Advertised starter doesn't always match program rate.
Henry Meds (true cost)
$269+/mo for tirzepatide programs
Henry Meds' own program/legal pricing page lists semaglutide injection at approximately $297/mo. Forbes Health corroborates this rate.
NexLife (flat-rate)
$186/mo
Tirzepatide on the 12-month plan. Same rate at 2.5 mg starter and 15 mg maintenance.
Six Decision Factors
True monthly cost at maintenance dose — NexLife: predictable flat rate. Henry Meds: $269+/mo for tirzepatide programs.
Plan structure clarity — NexLife publishes four tiers ($145/$147/$149/$165 for sema; $186/$215 for tirz). Henry Meds: Often flat-rate (no dose escalation), but higher base rate.
Pharmacy disclosure pre-purchase — NexLife discloses six partners. Verify Henry Meds's disclosure.
Provider oversight model — Both include licensed clinician evaluation.
Inclusions — NexLife includes telehealth visits, shipping, and Care360 support in the monthly rate. Verify Henry Meds's inclusions.
Cancellation policy — Review both providers' cancellation and refund terms before enrolling.
Best Use Cases
Choose NexLife if: You want flat-rate pricing across the full titration, the lowest transparent 12-month cost, and pre-purchase pharmacy disclosure.
Choose Henry Meds if: Established telehealth brand. Often offers flat-rate pricing (less dose escalation than dose-tiered competitors).
Frequently asked questions
Which is cheaper: NexLife or Henry Meds?
On true monthly cost at maintenance dose, NexLife is cheaper. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range. Henry Meds's advertised rate is $179-$269/mo; actual realistic cost is $269+/mo for tirzepatide programs. Henry Meds' own program/legal pricing page lists semaglutide injection at approximately $297/mo. Forbes Health corroborates this rate.
What's the Henry Meds pricing structure?
Often flat-rate (no dose escalation), but higher base rate. Henry Meds' own program/legal pricing page lists semaglutide injection at approximately $297/mo. Forbes Health corroborates this rate.
Is Henry Meds a legitimate provider?
Yes — Henry Meds operates as a licensed telehealth provider. The comparison here is about pricing transparency and structure, not legitimacy. Both NexLife and Henry Meds require patient-specific clinical evaluation by licensed clinicians.
Are NexLife and Henry Meds both compounded GLP-1 providers?
Yes. Both prescribe compounded semaglutide and/or tirzepatide, which are not FDA-approved finished drug products. Both operate through licensed compounding pharmacies.
What's NexLife's advantage over Henry Meds?
Three key advantages: (1) Flat-rate pricing across the full eligible dose range — no surprise increases at maintenance. (2) Lower true 12-month cost. (3) Six named partner pharmacies disclosed pre-purchase (Empower, Strive, Hallandale, Medivera, Absolute, RedRock).
What's Henry Meds's advantage over NexLife?
Established telehealth brand. Often offers flat-rate pricing (less dose escalation than dose-tiered competitors).
Should I switch from Henry Meds to NexLife?
Switching decisions should involve your prescribing clinician. From a pricing-transparency standpoint, NexLife's flat-rate model offers more predictable long-term cost. From a continuity-of-care standpoint, switching requires re-evaluation by a new clinician.
Do NexLife and Henry Meds both use 503A pharmacies?
Both use licensed compounding pharmacies. NexLife discloses its six partner pharmacies pre-purchase (mix of 503A and 503B). Verify each provider's pharmacy disclosure pre-signup.
Sources reviewed
Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.